{
  "schema_version": "2.0",
  "description": "朝聚眼科医疗控股有限公司的双语结构化披露数据，覆盖公司简介、2025 年业绩、消费眼科与基础眼科、医院网络、就诊量、现金流、管理层、风险及五年财务。",
  "description_en": "Bilingual structured disclosure data for Chaoju Eye Care Holdings Limited, covering the company summary, FY2025 results, consumer and basic ophthalmic services, hospital network, patient visits, cash flow, management, risks and five-year financials.",
  "scope": "HKEX 2021–2025 annual reports and formal disclosure reviewed through 17 July 2026; financial and operating data are presented through FY2025.",
  "methodology_url": "https://pureir.top/#method",
  "usage_notice": "PureIR 为独立、非官方信息平台。本数据用于帮助阅读正式披露，不构成投资建议，也不替代原始文件。",
  "usage_notice_en": "PureIR is an independent, unofficial information platform. This dataset supports reading of formal disclosure; it is not investment advice and does not replace the original filings.",
  "publisher": {
    "name": "PureIR",
    "url": "https://pureir.top/"
  },
  "data_as_of": "2025-12-31",
  "last_reviewed": "2026-07-17",
  "company": {
    "name": "Chaoju Eye Care Holdings Limited",
    "name_zh": "朝聚眼科医疗控股有限公司",
    "stock_code": "02219",
    "exchange": "HKEX",
    "official_website": "https://www.chaojueye.com/",
    "investor_relations_email": "CJ@chaojueye.com",
    "investor_relations_contact_url": "https://www.chaojueye.com/",
    "investor_relations_email_source": {
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 86
    },
    "description": "朝聚眼科是中国北部眼科医疗服务集团，提供消费眼科及基础眼科服务。2025 年收入为人民币 1,360.360 百万元，净利润为人民币 177.408 百万元，毛利率为 42.2%；年末运营 31 家眼科医院和 32 家视光中心，覆盖 7 个省、直辖市及自治区。",
    "description_en": "Chaoju Eye Care is an ophthalmic medical service group in North China providing consumer and basic ophthalmic services. In 2025 it reported revenue of RMB1,360.360 million, net profit of RMB177.408 million and a gross margin of 42.2%; at year-end it operated 31 ophthalmic hospitals and 32 optical centres across seven provinces, municipalities and autonomous regions.",
    "summary_sources": [
      {
        "label": "五年财务概要",
        "label_en": "Five-year financial highlights",
        "source_type": "hkex_filing",
        "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
        "pdf_page": 5
      },
      {
        "label": "网络与就诊量",
        "label_en": "Network and patient visits",
        "source_type": "hkex_filing",
        "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
        "pdf_page": 11
      },
      {
        "label": "分业务收入",
        "label_en": "Revenue by business segment",
        "source_type": "hkex_filing",
        "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
        "pdf_page": 12
      }
    ]
  },
  "highlights": [
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net operating cash flow",
      "display": "RMB 339.4m",
      "display_en": "RMB339.4m",
      "period": "FY2025",
      "period_zh": "截至 2025 年 12 月 31 日止年度",
      "period_en": "Year ended 31 December 2025",
      "value": 339.411,
      "currency": "RMB",
      "unit": "million",
      "unit_display_zh": "人民币百万元",
      "unit_display_en": "RMB million",
      "detail": "公司在收入同比下降 3.2% 的年度仍实现经营现金净流入。",
      "detail_en": "The company remained operating-cash-flow positive in a year when revenue decreased by 3.2%.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 27
    },
    {
      "metric_id": "hospital_network",
      "label": "眼科医院网络",
      "label_en": "Ophthalmic hospital network",
      "display": "31 家医院",
      "display_en": "31 hospitals",
      "period": "2025-12-31",
      "period_zh": "截至 2025 年 12 月 31 日",
      "period_en": "As at 31 December 2025",
      "value": 31,
      "currency": "N/A",
      "unit": "hospitals",
      "unit_display_zh": "眼科医院",
      "unit_display_en": "ophthalmic hospitals",
      "detail": "另设 32 家视光中心，网络覆盖 7 个省、直辖市及自治区。",
      "detail_en": "The network also included 32 optical centres across seven provinces, municipalities and autonomous regions.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "final_dividend_per_share",
      "label": "拟派末期股息",
      "label_en": "Proposed final dividend",
      "display": "HK$0.2423 / 股",
      "display_en": "HK$0.2423/share",
      "period": "FY2025",
      "period_zh": "截至 2025 年 12 月 31 日止年度",
      "period_en": "Year ended 31 December 2025",
      "value": 0.2423,
      "currency": "HKD",
      "unit": "per share",
      "unit_display_zh": "每股港币",
      "unit_display_en": "HKD per share",
      "detail": "年报披露的董事会建议，须经股东批准；2024 年末期股息为每股 0.1193 港元并已支付。",
      "detail_en": "A Board recommendation disclosed in the annual report, subject to shareholder approval; the FY2024 final dividend of HKD0.1193 per share had been paid.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 31
    }
  ],
  "narrative": [
    {
      "title": "消费眼科与基础眼科双支柱",
      "title_en": "Two pillars: consumer and basic ophthalmic services",
      "text": "2025 年消费眼科与基础眼科收入占比分别为 50.7% 和 49.1%。前者包括屈光矫正、近视防控及视光产品，后者覆盖白内障、青光眼及眼底病等常见眼病。",
      "text_en": "Consumer and basic ophthalmic services represented 50.7% and 49.1% of 2025 revenue. The former includes refractive correction, myopia control and optical products; the latter covers common eye diseases such as cataract, glaucoma and fundus diseases.",
      "period": "FY2025",
      "value_type": "editorial_synthesis",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "title": "区域集群与标准化网络",
      "title_en": "Regional clusters and a standardised network",
      "text": "集团起源于 1988 年包头眼科诊所，2025 年末以 31 家医院形成区域集群，并以集中和标准化管理支持复制与扩展。",
      "text_en": "Originating from a Baotou eye clinic founded in 1988, the Group operated 31 hospitals in regional clusters at the end of 2025, supported by centralised and standardised management.",
      "period": "2025-12-31",
      "value_type": "editorial_synthesis",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 6
    },
    {
      "title": "价格压力下的经营韧性",
      "title_en": "Operating resilience amid pricing pressure",
      "text": "公司披露，2025 年收入受到竞争加剧、医保服务价格改革及人工晶体集采影响；同期经营活动现金流净额为人民币 339.4 百万元。",
      "text_en": "The company disclosed revenue pressure from intensified competition, medical-insurance service pricing reform and volume-based procurement of intraocular lenses; net operating cash flow was RMB339.4 million.",
      "period": "FY2025",
      "value_type": "editorial_synthesis",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    }
  ],
  "management": [
    {
      "name_zh": "张波洲",
      "name_en": "Zhang Bozhou",
      "role_zh": "董事会主席、执行董事、首席执行官",
      "role_en": "Chairman, Executive Director and Chief Executive Officer",
      "bio_zh": "负责制定发展战略及投资计划、设定年度经营目标并决定集团经营管理事项；拥有逾 35 年眼科医疗行业经验。",
      "bio_en": "Responsible for development strategy and investment plans, annual business objectives and operating and management decisions; has more than 35 years of ophthalmic medical experience.",
      "period": "2025 annual report",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 34,
      "portrait_status": "official_company_website",
      "portrait_src": "/assets/management/chaoju-zhang-bozhou.webp",
      "portrait_alt_zh": "朝聚眼科官网发布的张波洲官方肖像",
      "portrait_alt_en": "Official portrait of Zhang Bozhou published by Chaoju Eye Care",
      "portrait_width": 800,
      "portrait_height": 957,
      "portrait_source_url": "https://www.chaojueye.com/manager/31.html",
      "portrait_asset_url": "https://www.chaojueye.com/static/uploads/image/20241217/cjglc-zbz.webp",
      "portrait_source_type": "company_website",
      "portrait_reviewed": "2026-07-17"
    },
    {
      "name_zh": "符锦",
      "name_en": "Fu Jin",
      "role_zh": "首席财务官",
      "role_en": "Chief Financial Officer",
      "bio_zh": "2023 年加入集团，负责整体财务运营，包括财务管理、融资投资及战略财务规划；拥有近 20 年财务会计经验。",
      "bio_en": "Joined the Group in 2023 and oversees financial operations, including financial management, financing, investment and strategic financial planning; has nearly 20 years of finance and accounting experience.",
      "period": "2025 annual report",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 39,
      "portrait_status": "official_company_website",
      "portrait_src": "/assets/management/chaoju-fu-jin.webp",
      "portrait_alt_zh": "朝聚眼科官网发布的符锦官方肖像",
      "portrait_alt_en": "Official portrait of Fu Jin published by Chaoju Eye Care",
      "portrait_width": 800,
      "portrait_height": 957,
      "portrait_source_url": "https://www.chaojueye.com/manager/29.html",
      "portrait_asset_url": "https://www.chaojueye.com/static/uploads/image/20250310/fj.png",
      "portrait_source_type": "company_website",
      "portrait_reviewed": "2026-07-17"
    },
    {
      "name_zh": "杨亚军",
      "name_en": "Yang Yajun",
      "role_zh": "首席医疗官",
      "role_en": "Chief Medical Officer",
      "bio_zh": "负责集团医疗质量控制、供应链管理及信息管理，2017 年起出任首席医疗官，拥有逾 33 年眼科医疗经验。",
      "bio_en": "Responsible for medical quality control, supply-chain management and information management; appointed chief medical officer in 2017 and has more than 33 years of ophthalmic medical experience.",
      "period": "2025 annual report",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 39,
      "portrait_status": "official_company_website",
      "portrait_src": "/assets/management/chaoju-yang-yajun.webp",
      "portrait_alt_zh": "朝聚眼科官网发布的杨亚军官方肖像",
      "portrait_alt_en": "Official portrait of Yang Yajun published by Chaoju Eye Care",
      "portrait_width": 800,
      "portrait_height": 957,
      "portrait_source_url": "https://www.chaojueye.com/manager/33.html",
      "portrait_asset_url": "https://www.chaojueye.com/static/uploads/image/20241217/cjglc-yyj.webp",
      "portrait_source_type": "company_website",
      "portrait_reviewed": "2026-07-17"
    },
    {
      "name_zh": "刘洪雁",
      "name_en": "Liu Hongyan",
      "role_zh": "首席运营官",
      "role_en": "Chief Operating Officer",
      "bio_zh": "负责市场与整体业务发展、销售策略及运营管理，并协助首席执行官制定业务发展计划与评估经营表现。",
      "bio_en": "Responsible for marketing, overall business development, sales strategy and operations, and assists the chief executive officer with business planning and performance evaluation.",
      "period": "2025 annual report",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 40,
      "portrait_status": "official_company_website",
      "portrait_src": "/assets/management/chaoju-liu-hongyan.webp",
      "portrait_alt_zh": "朝聚眼科官网发布的刘洪雁官方肖像",
      "portrait_alt_en": "Official portrait of Liu Hongyan published by Chaoju Eye Care",
      "portrait_width": 800,
      "portrait_height": 957,
      "portrait_source_url": "https://www.chaojueye.com/manager/30.html",
      "portrait_asset_url": "https://www.chaojueye.com/static/uploads/image/20250512/lz.webp",
      "portrait_source_type": "company_website",
      "portrait_reviewed": "2026-07-17"
    }
  ],
  "risks": [
    {
      "title": "价格改革、集采与竞争",
      "title_en": "Pricing reform, procurement and competition",
      "text": "医保服务价格改革、人工晶体集采及行业竞争可能影响服务价格、收入与利润率；公司披露这些因素已影响 2025 年收入。",
      "text_en": "Medical-insurance pricing reform, volume-based procurement of intraocular lenses and industry competition may affect service pricing, revenue and margins; the company disclosed an impact on 2025 revenue.",
      "period": "FY2025",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "title": "医疗质量与牌照",
      "title_en": "Medical quality and licensing",
      "text": "集团经营医院及视光中心，持续依赖医疗质量管理、专业人员及相关许可；医疗安全或合规事件可能影响业务和声誉。",
      "text_en": "Operation of hospitals and optical centres depends on medical-quality management, professionals and relevant licences; medical-safety or compliance events may affect the business and reputation.",
      "period": "2025 annual report",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 7
    },
    {
      "title": "扩张与资本投入",
      "title_en": "Expansion and capital expenditure",
      "text": "医院升级、新建与收购需要持续资本投入；2025 年末资本承担约人民币 103.7 百万元，现金流与融资能力会影响扩张节奏。",
      "text_en": "Hospital upgrades, new facilities and acquisitions require continuing capital; year-end 2025 capital commitments were approximately RMB103.7 million, making cash flow and financing capacity relevant to expansion.",
      "period": "2025-12-31",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 28
    },
    {
      "title": "结构性存款与理财产品",
      "title_en": "Structured deposits and wealth-management products",
      "text": "集团使用临时闲置资金配置银行理财与结构性存款；截至 2025 年末相关理财产品本金为人民币 190.0 百万元，占总资产 6.3%。",
      "text_en": "The Group allocates temporary surplus cash to bank wealth-management products and structured deposits; principal outstanding at year-end 2025 was RMB190.0 million, or 6.3% of total assets.",
      "period": "2025-12-31",
      "value_type": "company_disclosure_summary",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 28
    }
  ],
  "reports": [
    {
      "year": 2025,
      "published": "2026-04-21",
      "title": "2025 Annual Report",
      "title_zh": "2025 年报",
      "url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pages": 193
    },
    {
      "year": 2024,
      "published": "2025-04-28",
      "title": "2024 Annual Report",
      "title_zh": "2024 年报",
      "url": "https://www.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042800797.pdf",
      "pages": 201
    },
    {
      "year": 2023,
      "published": "2024-04-25",
      "title": "2023 Annual Report",
      "title_zh": "2023 年报",
      "url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pages": 193
    },
    {
      "year": 2022,
      "published": "2023-04-25",
      "title": "2022 Annual Report",
      "title_zh": "2022 年报",
      "url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pages": 185
    },
    {
      "year": 2021,
      "published": "2022-04-25",
      "title": "2021 Annual Report",
      "title_zh": "2021 年报",
      "url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pages": 175
    }
  ],
  "announcements": [],
  "financials": [
    {
      "metric_id": "revenue",
      "label": "收入",
      "label_en": "Revenue",
      "period": "FY2021",
      "value": 997.787,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_profit",
      "label": "毛利",
      "label_en": "Gross profit",
      "period": "FY2021",
      "value": 448.674,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "net_profit",
      "label": "净利润",
      "label_en": "Net profit",
      "period": "FY2021",
      "value": 157.641,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "revenue",
      "label": "收入",
      "label_en": "Revenue",
      "period": "FY2022",
      "value": 990.044,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_profit",
      "label": "毛利",
      "label_en": "Gross profit",
      "period": "FY2022",
      "value": 434.697,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "net_profit",
      "label": "净利润",
      "label_en": "Net profit",
      "period": "FY2022",
      "value": 183.196,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "revenue",
      "label": "收入",
      "label_en": "Revenue",
      "period": "FY2023",
      "value": 1369.505,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_profit",
      "label": "毛利",
      "label_en": "Gross profit",
      "period": "FY2023",
      "value": 621.134,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "net_profit",
      "label": "净利润",
      "label_en": "Net profit",
      "period": "FY2023",
      "value": 220.735,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "revenue",
      "label": "收入",
      "label_en": "Revenue",
      "period": "FY2024",
      "value": 1405.454,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_profit",
      "label": "毛利",
      "label_en": "Gross profit",
      "period": "FY2024",
      "value": 611.302,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "net_profit",
      "label": "净利润",
      "label_en": "Net profit",
      "period": "FY2024",
      "value": 186.21,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "revenue",
      "label": "收入",
      "label_en": "Revenue",
      "period": "FY2025",
      "value": 1360.36,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_profit",
      "label": "毛利",
      "label_en": "Gross profit",
      "period": "FY2025",
      "value": 573.901,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "net_profit",
      "label": "净利润",
      "label_en": "Net profit",
      "period": "FY2025",
      "value": 177.408,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    },
    {
      "metric_id": "gross_margin",
      "label": "毛利率",
      "label_en": "Gross margin",
      "period": "FY2025",
      "value": 42.2,
      "currency": "N/A",
      "unit": "percent",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 5
    }
  ],
  "business_revenue": [
    {
      "metric_id": "consumer_ophthalmic_revenue",
      "label": "消费眼科服务收入",
      "label_en": "Consumer ophthalmic services revenue",
      "period": "FY2021",
      "value": 517.233,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "basic_ophthalmic_revenue",
      "label": "基础眼科服务收入",
      "label_en": "Basic ophthalmic services revenue",
      "period": "FY2021",
      "value": 479.712,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "other_equipment_revenue",
      "label": "其他／设备及医用耗材销售",
      "label_en": "Other / equipment and medical-consumables sales",
      "period": "FY2021",
      "value": 0.842,
      "currency": "RMB",
      "unit": "million",
      "comparability_note_zh": "该项在 2021 年报列为“其他”。",
      "comparability_note_en": "This line was disclosed as “Others” in the FY2021 annual report.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "consumer_ophthalmic_revenue",
      "label": "消费眼科服务收入",
      "label_en": "Consumer ophthalmic services revenue",
      "period": "FY2022",
      "value": 542.873,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "basic_ophthalmic_revenue",
      "label": "基础眼科服务收入",
      "label_en": "Basic ophthalmic services revenue",
      "period": "FY2022",
      "value": 447.171,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "other_equipment_revenue",
      "label": "其他／设备及医用耗材销售",
      "label_en": "Other / equipment and medical-consumables sales",
      "period": "FY2022",
      "value": 0,
      "currency": "RMB",
      "unit": "million",
      "comparability_note_zh": "2022 年报该项以横线列示；为使分部合计与收入一致，图表按 0 展示。",
      "comparability_note_en": "The FY2022 annual report displayed a dash for this line; the chart shows zero so the business lines reconcile to revenue.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "consumer_ophthalmic_revenue",
      "label": "消费眼科服务收入",
      "label_en": "Consumer ophthalmic services revenue",
      "period": "FY2023",
      "value": 709.225,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "basic_ophthalmic_revenue",
      "label": "基础眼科服务收入",
      "label_en": "Basic ophthalmic services revenue",
      "period": "FY2023",
      "value": 654.011,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "other_equipment_revenue",
      "label": "其他／设备及医用耗材销售",
      "label_en": "Other / equipment and medical-consumables sales",
      "period": "FY2023",
      "value": 6.269,
      "currency": "RMB",
      "unit": "million",
      "comparability_note_zh": "该项在 2023 年报列为“设备销售”。",
      "comparability_note_en": "This line was disclosed as sales of equipment in the FY2023 annual report.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "consumer_ophthalmic_revenue",
      "label": "消费眼科服务收入",
      "label_en": "Consumer ophthalmic services revenue",
      "period": "FY2024",
      "value": 706.445,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "basic_ophthalmic_revenue",
      "label": "基础眼科服务收入",
      "label_en": "Basic ophthalmic services revenue",
      "period": "FY2024",
      "value": 697.84,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "other_equipment_revenue",
      "label": "其他／设备及医用耗材销售",
      "label_en": "Other / equipment and medical-consumables sales",
      "period": "FY2024",
      "value": 1.169,
      "currency": "RMB",
      "unit": "million",
      "comparability_note_zh": "该项自 2024 年起列为“设备及医用耗材销售”。",
      "comparability_note_en": "From FY2024 this line was disclosed as sales of equipment and medical consumables.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "consumer_ophthalmic_revenue",
      "label": "消费眼科服务收入",
      "label_en": "Consumer ophthalmic services revenue",
      "period": "FY2025",
      "value": 689.538,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "basic_ophthalmic_revenue",
      "label": "基础眼科服务收入",
      "label_en": "Basic ophthalmic services revenue",
      "period": "FY2025",
      "value": 667.639,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    },
    {
      "metric_id": "other_equipment_revenue",
      "label": "其他／设备及医用耗材销售",
      "label_en": "Other / equipment and medical-consumables sales",
      "period": "FY2025",
      "value": 3.183,
      "currency": "RMB",
      "unit": "million",
      "comparability_note_zh": "该项列为“设备及医用耗材销售”。",
      "comparability_note_en": "This line was disclosed as sales of equipment and medical consumables.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 12
    }
  ],
  "operating_metrics": [
    {
      "metric_id": "ophthalmic_hospitals",
      "label": "眼科医院",
      "label_en": "Ophthalmic hospitals",
      "period": "2025-12-31",
      "value": 31,
      "currency": "N/A",
      "unit": "hospitals",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "optical_centres",
      "label": "视光中心",
      "label_en": "Optical centres",
      "period": "2025-12-31",
      "value": 32,
      "currency": "N/A",
      "unit": "centres",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "outpatient_visits",
      "label": "门诊人次",
      "label_en": "Outpatient visits",
      "period": "FY2021",
      "value": 887335,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 10
    },
    {
      "metric_id": "inpatient_visits",
      "label": "住院人次",
      "label_en": "Inpatient visits",
      "period": "FY2021",
      "value": 45977,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 10
    },
    {
      "metric_id": "outpatient_visits",
      "label": "门诊人次",
      "label_en": "Outpatient visits",
      "period": "FY2022",
      "value": 944523,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "inpatient_visits",
      "label": "住院人次",
      "label_en": "Inpatient visits",
      "period": "FY2022",
      "value": 44581,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "outpatient_visits",
      "label": "门诊人次",
      "label_en": "Outpatient visits",
      "period": "FY2023",
      "value": 1128719,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 10
    },
    {
      "metric_id": "inpatient_visits",
      "label": "住院人次",
      "label_en": "Inpatient visits",
      "period": "FY2023",
      "value": 67258,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 10
    },
    {
      "metric_id": "outpatient_visits",
      "label": "门诊人次",
      "label_en": "Outpatient visits",
      "period": "FY2024",
      "value": 1137742,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "outpatient_visits",
      "label": "门诊人次",
      "label_en": "Outpatient visits",
      "period": "FY2025",
      "value": 1061851,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "inpatient_visits",
      "label": "住院人次",
      "label_en": "Inpatient visits",
      "period": "FY2024",
      "value": 72120,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    },
    {
      "metric_id": "inpatient_visits",
      "label": "住院人次",
      "label_en": "Inpatient visits",
      "period": "FY2025",
      "value": 69747,
      "currency": "N/A",
      "unit": "visits",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 11
    }
  ],
  "cash_flow": [
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net cash flows from operating activities",
      "period": "FY2021",
      "value": 249.394,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 24
    },
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net cash flows from operating activities",
      "period": "FY2022",
      "value": 273.41,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 26
    },
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net cash flows from operating activities",
      "period": "FY2023",
      "value": 372.569,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 24
    },
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net cash flows from operating activities",
      "period": "FY2024",
      "value": 354.355,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042800797.pdf",
      "pdf_page": 27
    },
    {
      "metric_id": "net_operating_cash",
      "label": "经营活动现金流净额",
      "label_en": "Net cash flows from operating activities",
      "period": "FY2025",
      "value": 339.411,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 27
    },
    {
      "metric_id": "cash_and_cash_equivalents",
      "label": "现金及现金等价物",
      "label_en": "Cash and cash equivalents",
      "period": "2025-12-31",
      "value": 516.339,
      "currency": "RMB",
      "unit": "million",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 98
    }
  ],
  "shareholder_returns": [
    {
      "metric_id": "final_dividend_per_share",
      "label": "末期股息",
      "label_en": "Final dividend",
      "period": "FY2021",
      "value": 0.1043,
      "currency": "HKD",
      "unit": "per share",
      "comparability_note_zh": "2021 年报披露的建议末期股息，须经股东批准。",
      "comparability_note_en": "Proposed final dividend disclosed in the FY2021 annual report, subject to shareholder approval.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2022/0425/2022042502516.pdf",
      "pdf_page": 7
    },
    {
      "metric_id": "final_dividend_per_share",
      "label": "末期股息",
      "label_en": "Final dividend",
      "period": "FY2022",
      "value": 0.1738,
      "currency": "HKD",
      "unit": "per share",
      "comparability_note_zh": "2022 年报披露的建议末期股息，须经股东批准。",
      "comparability_note_en": "Proposed final dividend disclosed in the FY2022 annual report, subject to shareholder approval.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2023/0425/2023042502721.pdf",
      "pdf_page": 30
    },
    {
      "metric_id": "final_dividend_per_share",
      "label": "末期股息",
      "label_en": "Final dividend",
      "period": "FY2023",
      "value": 0.2208,
      "currency": "HKD",
      "unit": "per share",
      "comparability_note_zh": "2023 年报披露的建议末期股息；另建议每股 0.0767 港元特别股息，未并入本序列。",
      "comparability_note_en": "Proposed final dividend disclosed in the FY2023 annual report; a separate proposed special dividend of HKD0.0767 per share is excluded from this series.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500954.pdf",
      "pdf_page": 27
    },
    {
      "metric_id": "final_dividend_per_share",
      "label": "末期股息",
      "label_en": "Final dividend",
      "period": "FY2024",
      "value": 0.1193,
      "currency": "HKD",
      "unit": "per share",
      "comparability_note_zh": "2024 年报披露的建议末期股息，须经股东批准。",
      "comparability_note_en": "Proposed final dividend disclosed in the FY2024 annual report, subject to shareholder approval.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www.hkexnews.hk/listedco/listconews/sehk/2025/0428/2025042800797.pdf",
      "pdf_page": 31
    },
    {
      "metric_id": "final_dividend_per_share",
      "label": "末期股息",
      "label_en": "Final dividend",
      "period": "FY2025",
      "value": 0.2423,
      "currency": "HKD",
      "unit": "per share",
      "comparability_note_zh": "2025 年报披露的董事会建议，须经股东批准。",
      "comparability_note_en": "Board recommendation disclosed in the FY2025 annual report, subject to shareholder approval.",
      "value_type": "company_disclosure",
      "source_type": "hkex_filing",
      "source_url": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0421/2026042100239.pdf",
      "pdf_page": 31
    }
  ],
  "publication_relationship": {
    "type": "unpaid_pilot",
    "labelZh": "免费试点页面",
    "labelEn": "Unpaid pilot profile",
    "disclosureZh": "本页为 PureIR 免费试点页面，由 PureIR 根据正式披露独立整理；公司未付费委托，也未参与评级或投资判断。",
    "disclosureEn": "This is an unpaid PureIR pilot independently prepared from formal disclosure. The company did not commission or pay for the profile and did not participate in any rating or investment judgement."
  }
}